Heart bypass gets safer? new drug trial aims to prevent clots during surgery

NCT ID NCT07514962

First seen Apr 14, 2026 · Last updated May 20, 2026 · Updated 5 times

Summary

This study tests whether giving the blood thinner cangrelor during a minimally invasive heart bypass (MIDCAB) is safe and helps prevent dangerous blood clots. About 30 adults with coronary artery disease will receive cangrelor through an IV during surgery, and their outcomes will be compared to past patients who had the same surgery without it. The goal is to see if this approach reduces complications without increasing bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Istituto Cardiocentro Ticino

    RECRUITING

    Lugano, Ch/ti, 6900, Switzerland

    Contact Phone: •••-•••-••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.